Antineurofilament antibodies in postpolio syndrome.

Drory, V E; Shapira, A; Korczyn, A D; Shavit, S; Kushnir, M; Michaelson, D M; Chapman, J · Neurology · 1998

cross_sectional · Level IV

Where this comes from

Abstract

We determined the levels of antineurofilament antibodies in 29 patients with postpolio syndrome (PPS), 26 stable postpolio (PP) patients, 22 patients with ALS, and 20 normal controls (NCs). Patients with PPS had higher antibody levels to cholinergic neurofilaments than did all other groups. PP patients and those with ALS had antibody levels similar to those of NCs. The antibody binding level showed no relation to the age of the patients, duration of disease, or motor score.

Medical subject headings